APO Research
Talk to an analyst

APO RESEARCH · REPORT

Laxatives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Laxatives Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchLaxatives Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Laxatives Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Laxatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laxatives Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Laxatives Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Laxatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Laxatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Laxatives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Laxatives market include Abbott Laboratories, Boehringer Ingelheim, Braintree Laboratories, Purdue Pharma, Sucampo Pharmaceuticals, AstraZeneca, Bayer, GlaxoSmithKline and Takeda Pharmaceutical Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Laxatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laxatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laxatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Laxatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Laxatives Segment by Company

Abbott Laboratories

Boehringer Ingelheim

Braintree Laboratories

Purdue Pharma

Sucampo Pharmaceuticals

AstraZeneca

Bayer

GlaxoSmithKline

Takeda Pharmaceutical Company

Laxatives Segment by Type

Lubricating Laxative

Volumetric Laxative

Swelling Laxative

Hypertonic Laxative

Stimulant Laxative

Others

Laxatives Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Laxatives Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Laxatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Laxatives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laxatives significant trends, drivers, influence factors in global and regions.

6. To analyze Laxatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laxatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laxatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laxatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Laxatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laxatives industry.

Chapter 3: Detailed analysis of Laxatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Laxatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Laxatives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laxatives Industry Trends Table 2. Laxatives Industry Drivers Table 3. Laxatives Industry Opportunities and Challenges Table 4. Laxatives Industry Restraints Table 5. Global Laxatives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laxatives Revenue Share by Company (2021-2026) Table 7. Global Laxatives Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Laxatives Sales Volume Share by Company (2021-2026) Table 9. Global Laxatives Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Laxatives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Laxatives Key Company Manufacturing Base & Headquarters Table 12. Global Laxatives Company, Product Type & Application Table 13. Global Laxatives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Laxatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lubricating Laxative Table 18. Significant Companies of Volumetric Laxative Table 19. Significant Companies of Swelling Laxative Table 20. Significant Companies of Hypertonic Laxative Table 21. Significant Companies of Stimulant Laxative Table 22. Significant Companies of Others Table 23. Global Laxatives Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Laxatives Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Laxatives Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Laxatives Sales Volume Share by Type (2021-2026) Table 27. Global Laxatives Sales Volume Share by Type (2027-2032) Table 28. Global Laxatives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Laxatives Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Laxatives Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Laxatives Sales Value Share by Type (2021-2026) Table 32. Global Laxatives Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hospital Pharmacies Table 34. Significant Companies of Online Pharmacies Table 35. Significant Companies of Retail Pharmacies Table 36. Global Laxatives Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Laxatives Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Laxatives Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Laxatives Sales Volume Share by Application (2021-2026) Table 40. Global Laxatives Sales Volume Share by Application (2027-2032) Table 41. Global Laxatives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Laxatives Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Laxatives Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Laxatives Sales Value Share by Application (2021-2026) Table 45. Global Laxatives Sales Value Share by Application (2027-2032) Table 46. Global Laxatives Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Laxatives Sales by Region (2021-2026) & (K Units) Table 48. Global Laxatives Sales Market Share by Region (2021-2026) Table 49. Global Laxatives Sales by Region (2027-2032) & (K Units) Table 50. Global Laxatives Sales Market Share by Region (2027-2032) Table 51. Global Laxatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Laxatives Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Laxatives Sales Value Share by Region (2021-2026) Table 54. Global Laxatives Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Laxatives Sales Value Share by Region (2027-2032) Table 56. Global Laxatives Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Laxatives Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Laxatives Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Laxatives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Laxatives Sales by Country (2021-2026) & (K Units) Table 61. Global Laxatives Sales Market Share by Country (2021-2026) Table 62. Global Laxatives Sales by Country (2027-2032) & (K Units) Table 63. Global Laxatives Sales Market Share by Country (2027-2032) Table 64. Global Laxatives Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Laxatives Sales Value Market Share by Country (2021-2026) Table 66. Global Laxatives Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Laxatives Sales Value Market Share by Country (2027-2032) Table 68. Abbott Laboratories Company Information Table 69. Abbott Laboratories Business Overview Table 70. Abbott Laboratories Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Abbott Laboratories Laxatives Product Portfolio Table 72. Abbott Laboratories Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Laxatives Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Braintree Laboratories Company Information Table 79. Braintree Laboratories Business Overview Table 80. Braintree Laboratories Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Braintree Laboratories Laxatives Product Portfolio Table 82. Braintree Laboratories Recent Development Table 83. Purdue Pharma Company Information Table 84. Purdue Pharma Business Overview Table 85. Purdue Pharma Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Purdue Pharma Laxatives Product Portfolio Table 87. Purdue Pharma Recent Development Table 88. Sucampo Pharmaceuticals Company Information Table 89. Sucampo Pharmaceuticals Business Overview Table 90. Sucampo Pharmaceuticals Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sucampo Pharmaceuticals Laxatives Product Portfolio Table 92. Sucampo Pharmaceuticals Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Laxatives Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Bayer Laxatives Product Portfolio Table 102. Bayer Recent Development Table 103. GlaxoSmithKline Company Information Table 104. GlaxoSmithKline Business Overview Table 105. GlaxoSmithKline Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GlaxoSmithKline Laxatives Product Portfolio Table 107. GlaxoSmithKline Recent Development Table 108. Takeda Pharmaceutical Company Company Information Table 109. Takeda Pharmaceutical Company Business Overview Table 110. Takeda Pharmaceutical Company Laxatives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Takeda Pharmaceutical Company Laxatives Product Portfolio Table 112. Takeda Pharmaceutical Company Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Laxatives Distributors List Table 116. Laxatives Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Laxatives Product Image Figure 2. Global Laxatives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laxatives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Laxatives Sales (2021-2032) & (K Units) Figure 5. Global Laxatives Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Laxatives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lubricating Laxative Image Figure 10. Volumetric Laxative Image Figure 11. Swelling Laxative Image Figure 12. Hypertonic Laxative Image Figure 13. Stimulant Laxative Image Figure 14. Others Image Figure 15. Global Laxatives Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Laxatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Laxatives Sales Volume Share by Type (2021-2032) Figure 18. Global Laxatives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Laxatives Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Laxatives Sales Value Share by Type (2021-2032) Figure 21. Hospital Pharmacies Image Figure 22. Online Pharmacies Image Figure 23. Retail Pharmacies Image Figure 24. Global Laxatives Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Laxatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Laxatives Sales Volume Share by Application (2021-2032) Figure 27. Global Laxatives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Laxatives Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Laxatives Sales Value Share by Application (2021-2032) Figure 30. Global Laxatives Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Laxatives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Laxatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Laxatives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Laxatives Sales Value (2021-2032) & (US$ Million) Figure 35. North America Laxatives Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Laxatives Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Laxatives Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Laxatives Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Laxatives Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Laxatives Sales Value (2021-2032) & (US$ Million) Figure 41. South America Laxatives Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Laxatives Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Laxatives Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Laxatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Laxatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Laxatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Laxatives Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Laxatives Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Lubricating Laxative
  • Volumetric Laxative
  • Swelling Laxative
  • Hypertonic Laxative
  • Stimulant Laxative
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Abbott Laboratories
  • Boehringer Ingelheim
  • Braintree Laboratories
  • Purdue Pharma
  • Sucampo Pharmaceuticals
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Takeda Pharmaceutical Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Laxatives Sales Value (2021-2032)
  4. 1.2.2 Global Laxatives Sales Volume (2021-2032)
  5. 1.2.3 Global Laxatives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Laxatives Market Dynamics
  1. 2.1 Laxatives Industry Trends
  2. 2.2 Laxatives Industry Drivers
  3. 2.3 Laxatives Industry Opportunities and Challenges
  4. 2.4 Laxatives Industry Restraints
3 Laxatives Market by Company
  1. 3.1 Global Laxatives Company Revenue Ranking in 2025
  2. 3.2 Global Laxatives Revenue by Company (2021-2026)
  3. 3.3 Global Laxatives Sales Volume by Company (2021-2026)
  4. 3.4 Global Laxatives Average Price by Company (2021-2026)
  5. 3.5 Global Laxatives Company Ranking (2024-2026)
  6. 3.6 Global Laxatives Company Manufacturing Base and Headquarters
  7. 3.7 Global Laxatives Company Product Type and Application
  8. 3.8 Global Laxatives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Laxatives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Laxatives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Laxatives Market by Type
  1. 4.1 Laxatives Type Introduction
  2. 4.1.1 Lubricating Laxative
  3. 4.1.2 Volumetric Laxative
  4. 4.1.3 Swelling Laxative
  5. 4.1.4 Hypertonic Laxative
  6. 4.1.5 Stimulant Laxative
  7. 4.1.6 Others
  8. 4.2 Global Laxatives Sales Volume by Type
  9. 4.2.1 Global Laxatives Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Laxatives Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Laxatives Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Laxatives Sales Value by Type
  13. 4.3.1 Global Laxatives Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Laxatives Sales Value by Type (2021-2032)
  15. 4.3.3 Global Laxatives Sales Value Share by Type (2021-2032)
5 Laxatives Market by Application
  1. 5.1 Laxatives Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Laxatives Sales Volume by Application
  6. 5.2.1 Global Laxatives Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Laxatives Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Laxatives Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Laxatives Sales Value by Application
  10. 5.3.1 Global Laxatives Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Laxatives Sales Value by Application (2021-2032)
  12. 5.3.3 Global Laxatives Sales Value Share by Application (2021-2032)
6 Laxatives Regional Sales and Value Analysis
  1. 6.1 Global Laxatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laxatives Sales by Region (2021-2032)
  3. 6.2.1 Global Laxatives Sales by Region: 2021-2026
  4. 6.2.2 Global Laxatives Sales by Region (2027-2032)
  5. 6.3 Global Laxatives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Laxatives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Laxatives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Laxatives Sales Value by Region (2027-2032)
  9. 6.5 Global Laxatives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Laxatives Sales Value (2021-2032)
  12. 6.6.2 North America Laxatives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Laxatives Sales Value (2021-2032)
  15. 6.7.2 Europe Laxatives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Laxatives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Laxatives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Laxatives Sales Value (2021-2032)
  21. 6.9.2 South America Laxatives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Laxatives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Laxatives Sales Value Share by Country, 2025 VS 2032
7 Laxatives Country-level Sales and Value Analysis
  1. 7.1 Global Laxatives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laxatives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Laxatives Sales by Country (2021-2032)
  4. 7.3.1 Global Laxatives Sales by Country (2021-2026)
  5. 7.3.2 Global Laxatives Sales by Country (2027-2032)
  6. 7.4 Global Laxatives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Laxatives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Laxatives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Laxatives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Laxatives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Laxatives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Laxatives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Laxatives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Laxatives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Laxatives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Laxatives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Laxatives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Laxatives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Laxatives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Laxatives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Laxatives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Laxatives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Laxatives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Laxatives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Laxatives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Laxatives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Laxatives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Laxatives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Laxatives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Laxatives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Laxatives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Laxatives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Laxatives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Laxatives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Laxatives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Laxatives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Laxatives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Laxatives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Laxatives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Laxatives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Laxatives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Laxatives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Laxatives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Laxatives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Laxatives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Laxatives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Laxatives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Laxatives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Laxatives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Laxatives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Laxatives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Laxatives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Laxatives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Laxatives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Laxatives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Laxatives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Laxatives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Laxatives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Laxatives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Laxatives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Laxatives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Laxatives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Laxatives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Laxatives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Laxatives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Laxatives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Laxatives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Laxatives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Laxatives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Laxatives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Laxatives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Laxatives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Laxatives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Laxatives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Laxatives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Laxatives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Laxatives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Laxatives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Laxatives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Laxatives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Laxatives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Laxatives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Laxatives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Laxatives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Laxatives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Laxatives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Laxatives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Laxatives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Laxatives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Laxatives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Laxatives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Laxatives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Laxatives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Laxatives Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Laxatives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Laxatives Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Braintree Laboratories
  14. 8.3.1 Braintree Laboratories Company Information
  15. 8.3.2 Braintree Laboratories Business Overview
  16. 8.3.3 Braintree Laboratories Laxatives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Braintree Laboratories Laxatives Product Portfolio
  18. 8.3.5 Braintree Laboratories Recent Developments
  19. 8.4 Purdue Pharma
  20. 8.4.1 Purdue Pharma Company Information
  21. 8.4.2 Purdue Pharma Business Overview
  22. 8.4.3 Purdue Pharma Laxatives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Purdue Pharma Laxatives Product Portfolio
  24. 8.4.5 Purdue Pharma Recent Developments
  25. 8.5 Sucampo Pharmaceuticals
  26. 8.5.1 Sucampo Pharmaceuticals Company Information
  27. 8.5.2 Sucampo Pharmaceuticals Business Overview
  28. 8.5.3 Sucampo Pharmaceuticals Laxatives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sucampo Pharmaceuticals Laxatives Product Portfolio
  30. 8.5.5 Sucampo Pharmaceuticals Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Laxatives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Laxatives Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Laxatives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Laxatives Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Laxatives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Laxatives Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Takeda Pharmaceutical Company
  50. 8.9.1 Takeda Pharmaceutical Company Company Information
  51. 8.9.2 Takeda Pharmaceutical Company Business Overview
  52. 8.9.3 Takeda Pharmaceutical Company Laxatives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Pharmaceutical Company Laxatives Product Portfolio
  54. 8.9.5 Takeda Pharmaceutical Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Laxatives Value Chain Analysis
  2. 9.1.1 Laxatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Laxatives Sales Mode & Process
  6. 9.2 Laxatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Laxatives Distributors
  9. 9.2.3 Laxatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst